Terms: = Breast cancer AND ROS1, ROS, 6098, ENSG00000047936, P08922, MCF3, RP1-179P9_1
142661 results:
1. BECN1 mRNA expression in breast cancer tissue; significant correlation to tumor grade.
Aglan SA; Awad AM; Elwany YN; Shawky S; Salam RMA; Omar RS; Ghazala RAM; Soliman NA; Khedr MI; Kandil LS; Sultan M; Hamed Y; Kandil NS
Mol Genet Genomics; 2024 May; 299(1):56. PubMed ID: 38787424
[TBL] [Abstract] [Full Text] [Related]
2. Digital breast Tomosynthesis for Upgraded BIRADS Scoring towards the True Pathology of Lesions Detected by Contrast-Enhanced Mammography.
Grubstein A; Friehmann T; Dahan M; Abitbol C; Gadiel I; Schejtman DM; Shochat T; Atar E; Tamir S
Tomography; 2024 May; 10(5):806-815. PubMed ID: 38787021
[TBL] [Abstract] [Full Text] [Related]
3. Immunoglobulin Superfamily Containing Leucine-Rich Repeat (ISLR) Serves as a Redox Sensor That Modulates Antioxidant Capacity by Suppressing Pyruvate Kinase Isozyme M2 Activity.
Wang T; Chen M; Su Y; Zhang Y; Liu C; Lan M; Li L; Liu F; Li N; Yu Y; Xiong L; Wang K; Liu J; Xu Q; Hu Y; Jia Y; Cao Y; Pan J; Meng Q
Cells; 2024 May; 13(10):. PubMed ID: 38786060
[TBL] [Abstract] [Full Text] [Related]
4. Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial-Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative breast cancer.
Nair MG; Mavatkar AD; Naidu CM; V P S; C E A; Rajarajan S; Sahoo S; Mohan G; Jaikumar VS; Ramesh RS; B S S; Jolly MK; Maliekal TT; Prabhu JS
Cells; 2024 May; 13(10):. PubMed ID: 38786043
[TBL] [Abstract] [Full Text] [Related]
5. Exogenous Metabolic Modulators Improve Response to Carboplatin in Triple-Negative breast cancer.
Ho AN; Kiesel VA; Gates CE; Brosnan BH; Connelly SP; Glenny EM; Cozzo AJ; Hursting SD; Coleman MF
Cells; 2024 May; 13(10):. PubMed ID: 38786030
[TBL] [Abstract] [Full Text] [Related]
6. Sonographic Evaluation of Nigerian Women with Mammographic Focal Asymmetric Density.
Itanyi DU; Ibrahim H; Ka'alu WO
West Afr J Med; 2024 Mar; 41(3):233-237. PubMed ID: 38785292
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.
Chen L; Yan X; Luo T; Tian T; He P; Zhong X
Cancer Med; 2024 May; 13(10):e7295. PubMed ID: 38785215
[TBL] [Abstract] [Full Text] [Related]
8. Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya.
Elmaihub ES; Alhudiri I; Ramadan AM; Eljilani M; Elzagheid A; Elfagi F; Hassen E
Libyan J Med; 2024 Dec; 19(1):2356906. PubMed ID: 38785139
[TBL] [Abstract] [Full Text] [Related]
9. Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening.
Zhong Y; Le H; Zhang X; Dai Y; Guo F; Ran X; Hu G; Xie Q; Wang D; Cai Y
J Hematol Oncol; 2024 May; 17(1):36. PubMed ID: 38783389
[TBL] [Abstract] [Full Text] [Related]
10. Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.
Lambert V; Kane S; Howidi B; Nguyen BN; Chandiwana D; Wu Y; Edwards M; Samjoo IA
BMC Cancer; 2024 May; 24(1):631. PubMed ID: 38783218
[TBL] [Abstract] [Full Text] [Related]
11. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
He ZX; Li J; Wang QF; Cheng Q; Ni SJ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
[No Abstract] [Full Text] [Related]
12. [Feasibility analysis of the application of programmed process endoscopic lateral neck dissection via chest-breast approach in papillary thyroid carcinoma surgery].
Xu N; Li ZY; Luo XP; Gao HY; Huang JF; Wang YY; Liu XJ; Xu B
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1831-1836. PubMed ID: 38782751
[No Abstract] [Full Text] [Related]
13. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
[No Abstract] [Full Text] [Related]
14. cancer Treatment Before and After Physician-Pharmacy Integration.
Kanter GP; Ozluk P; Chi W; Fisch MJ; Debono D; Parikh RB; Jacobson M; Bekelman JE; DeVries A
JAMA Netw Open; 2024 May; 7(5):e2412998. PubMed ID: 38780938
[TBL] [Abstract] [Full Text] [Related]
15. Mechanistic evaluation of myristicin on apoptosis and cell cycle regulation in breast cancer cells.
Sufina Nazar S; Ayyappan JP
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23740. PubMed ID: 38779996
[TBL] [Abstract] [Full Text] [Related]
16. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer.
Cui Z; Li Y; Lin Y; Zheng C; Luo L; Hu D; Chen Y; Xiao Z; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1328679. PubMed ID: 38779451
[TBL] [Abstract] [Full Text] [Related]
17. Mutant p53 reactivators protect breast cancer cells from ferroptosis.
Rathnayake DS; Dlamini S; Elkalawozgy K; Tillekeratne LMV; Taylor WR
Cell Biochem Funct; 2024 Jun; 42(4):e4036. PubMed ID: 38778584
[TBL] [Abstract] [Full Text] [Related]
18. Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case report.
Chitnis SD; Seim NB; Kendra K
J Med Case Rep; 2024 May; 18(1):257. PubMed ID: 38778387
[TBL] [Abstract] [Full Text] [Related]
19. Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer.
Giannubilo I; Battistuzzi L; Blondeaux E; Ruelle T; Poggio FB; Buzzatti G; D'Alonzo A; Della Rovere F; Latocca MM; Molinelli C; Razeti MG; Nardin S; Arecco L; Perachino M; Favero D; Borea R; Pronzato P; Del Mastro L; Bighin C
BMC Palliat Care; 2024 May; 23(1):129. PubMed ID: 38778303
[TBL] [Abstract] [Full Text] [Related]
20. Effect of combination of Beta Glucan and Lactobacillus rhamnosus HerizI on white blood cell counts and serum levels of IL-4 and IL-12 in women with breast cancer undergoing chemotherapy: A randomized double-blind placebo-controlled clinical trial.
Ostadrahimi A; Ahmadikhatir S; Amirazad H; EivaziZiaei J; AsghariJafarabadi M; Barzeghari A; Esfahani A; Farrin N
Clin Nutr ESPEN; 2024 Jun; 61():281-287. PubMed ID: 38777445
[TBL] [Abstract] [Full Text] [Related]
[Next]